iScience (May 2021)

Adipose-mesenchymal stromal cells suppress experimental Sjögren syndrome by IL-33-driven expansion of ST2+ regulatory T cells

  • Ousheng Liu,
  • Junji Xu,
  • Fu Wang,
  • Wenwen Jin,
  • Peter Zanvit,
  • Dandan Wang,
  • Nathan Goldberg,
  • Alexander Cain,
  • Nancy Guo,
  • Yichen Han,
  • Andrew Bynum,
  • Guowu Ma,
  • Songlin Wang,
  • Zhangui Tang,
  • Wanjun Chen

Journal volume & issue
Vol. 24, no. 5
p. 102446

Abstract

Read online

Summary: Adipose-derived mesenchymal stromal cells (ADSCs) play important roles in the alleviation of inflammation and autoimmune diseases. Interleukin-33 (IL-33), a member of the IL-1 family, has been shown to regulate innate and adaptive immunity. However, it is still unknown whether ADSCs regulate immune responses via IL-33. We show here that ADSCs produced IL-33 in response to IL-1β stimulation, which depended on TAK1, ERK, and p38 pathways. ADSCs-derived IL-33 drove the proliferation of CD4+Foxp3+ST2+ regulatory T cells (Tregs) and alleviated experimental autoimmune Sjögren syndrome in mice. Importantly, human ADSCs also produced IL-33 in response to IL-1β. Thus, we have revealed a previously unrecognized immunoregulatory function of ADSCs by IL-33 production in experimental autoimmunity, which may have clinical applications for human immunopathology.

Keywords